Cargando…
Estimating total morbidity burden of COVID-19: relative importance of death and disability
OBJECTIVE: Calculations of disease burden of COVID-19, used to allocate scarce resources, have historically considered only mortality. However, survivors often develop postinfectious ‘long-COVID’ similar to chronic fatigue syndrome; physical sequelae such as heart damage, or both. This paper quantif...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547965/ https://www.ncbi.nlm.nih.gov/pubmed/34715312 http://dx.doi.org/10.1016/j.jclinepi.2021.10.018 |
_version_ | 1784590483860750336 |
---|---|
author | Smith, Maia P. |
author_facet | Smith, Maia P. |
author_sort | Smith, Maia P. |
collection | PubMed |
description | OBJECTIVE: Calculations of disease burden of COVID-19, used to allocate scarce resources, have historically considered only mortality. However, survivors often develop postinfectious ‘long-COVID’ similar to chronic fatigue syndrome; physical sequelae such as heart damage, or both. This paper quantifies relative contributions of acute case fatality, delayed case fatality, and disability to total morbidity per COVID-19 case. STUDY DESIGN AND SETTING: Healthy life years lost per COVID-19 case were computed as the sum of (incidence*disability weight*duration) for death and long-COVID by sex and 10-year age category in three plausible scenarios. RESULTS: In all models, acute mortality was only a small share of total morbidity. For lifelong moderate symptoms, healthy years lost per COVID-19 case ranged from 0.92 (male in his 30s) to 5.71 (girl under 10) and were 3.5 and 3.6 for the oldest females and males. At higher symptom severities, young people and females bore larger shares of morbidity; if survivors’ later mortality increased, morbidity increased most in young people of both sexes. CONCLUSIONS: Under most conditions most COVID-19 morbidity was in survivors. Future research should investigate incidence, risk factors, and clinical course of long-COVID to elucidate total disease burden, and decisionmakers should allocate scarce resources to minimize total morbidity. |
format | Online Article Text |
id | pubmed-8547965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85479652021-10-27 Estimating total morbidity burden of COVID-19: relative importance of death and disability Smith, Maia P. J Clin Epidemiol Original Article OBJECTIVE: Calculations of disease burden of COVID-19, used to allocate scarce resources, have historically considered only mortality. However, survivors often develop postinfectious ‘long-COVID’ similar to chronic fatigue syndrome; physical sequelae such as heart damage, or both. This paper quantifies relative contributions of acute case fatality, delayed case fatality, and disability to total morbidity per COVID-19 case. STUDY DESIGN AND SETTING: Healthy life years lost per COVID-19 case were computed as the sum of (incidence*disability weight*duration) for death and long-COVID by sex and 10-year age category in three plausible scenarios. RESULTS: In all models, acute mortality was only a small share of total morbidity. For lifelong moderate symptoms, healthy years lost per COVID-19 case ranged from 0.92 (male in his 30s) to 5.71 (girl under 10) and were 3.5 and 3.6 for the oldest females and males. At higher symptom severities, young people and females bore larger shares of morbidity; if survivors’ later mortality increased, morbidity increased most in young people of both sexes. CONCLUSIONS: Under most conditions most COVID-19 morbidity was in survivors. Future research should investigate incidence, risk factors, and clinical course of long-COVID to elucidate total disease burden, and decisionmakers should allocate scarce resources to minimize total morbidity. The Author. Published by Elsevier Inc. 2022-02 2021-10-26 /pmc/articles/PMC8547965/ /pubmed/34715312 http://dx.doi.org/10.1016/j.jclinepi.2021.10.018 Text en © 2021 The Author Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Smith, Maia P. Estimating total morbidity burden of COVID-19: relative importance of death and disability |
title | Estimating total morbidity burden of COVID-19: relative importance of death and disability |
title_full | Estimating total morbidity burden of COVID-19: relative importance of death and disability |
title_fullStr | Estimating total morbidity burden of COVID-19: relative importance of death and disability |
title_full_unstemmed | Estimating total morbidity burden of COVID-19: relative importance of death and disability |
title_short | Estimating total morbidity burden of COVID-19: relative importance of death and disability |
title_sort | estimating total morbidity burden of covid-19: relative importance of death and disability |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547965/ https://www.ncbi.nlm.nih.gov/pubmed/34715312 http://dx.doi.org/10.1016/j.jclinepi.2021.10.018 |
work_keys_str_mv | AT smithmaiap estimatingtotalmorbidityburdenofcovid19relativeimportanceofdeathanddisability |